Verus Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Sell |
59,240
-2,155
| -4% | -$400K | 0.91% | 20 |
|
|
2025
Q1 | $12.9M | Sell |
61,395
-1,768
| -3% | -$370K | 1.2% | 13 |
|
|
2024
Q4 | $11.2M | Sell |
63,163
-1,122
| -2% | -$199K | 1.01% | 15 |
|
|
2024
Q3 | $12.7M | Sell |
64,285
-669
| -1% | -$132K | 1.16% | 15 |
|
|
2024
Q2 | $11.1M | Buy |
64,954
+314
| +0.5% | +$53.9K | 1.08% | 15 |
|
|
2024
Q1 | $11.8M | Buy |
64,640
+990
| +2% | +$180K | 1.3% | 13 |
|
|
2023
Q4 | $9.86M | Sell |
63,650
-1,445
| -2% | -$224K | 1.21% | 16 |
|
|
2023
Q3 | $9.7M | Sell |
65,095
-11,540
| -15% | -$1.72M | 1.35% | 12 |
|
|
2023
Q2 | $10.3M | Sell |
76,635
-12,402
| -14% | -$1.67M | 1.46% | 11 |
|
|
2023
Q1 | $14.2M | Buy |
89,037
+6,300
| +8% | +$1M | 2.22% | 8 |
|
|
2022
Q4 | $13.4M | Sell |
82,737
-5,043
| -6% | -$815K | 2.51% | 8 |
|
|
2022
Q3 | $11.8M | Buy |
87,780
+24,606
| +39% | +$3.3M | 2.22% | 8 |
|
|
2022
Q2 | $14.6M | Sell |
63,174
-34,590
| -35% | -$8M | 2.86% | 6 |
|
|
2022
Q1 | $15M | Buy |
+97,764
| New | +$15M | 2.33% | 7 |
|
|
2020
Q1 | $1.55M | Buy |
20,282
+3,758
| +23% | +$286K | 0.49% | 38 |
|
|
2019
Q4 | $1.46M | Buy |
+16,524
| New | +$1.46M | 0.48% | 35 |
|